These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 35224957)

  • 21. Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.
    Bonates P; João GAP; Cruz KS; Ferreira MS; Baía-da-Silva DC; Farias MEL; Brito-Sousa JD; Santana MF; Oliveira LA; Cortez ACA; Souza JVB; Lacerda MVG
    Rev Soc Bras Med Trop; 2021; 54():e03582021. PubMed ID: 34259759
    [No Abstract]   [Full Text] [Related]  

  • 22. Response to: COVID-19-associated mucormycosis and evolving evidence.
    Sarda R; Swain S; Ray A; Wig N
    QJM; 2022 Jun; 115(6):422. PubMed ID: 34264346
    [No Abstract]   [Full Text] [Related]  

  • 23. Additional insights on COVID-associated mucormycosis.
    Panta P
    Br J Oral Maxillofac Surg; 2022 May; 60(4):e531-e532. PubMed ID: 35120786
    [No Abstract]   [Full Text] [Related]  

  • 24. Mucormycosis in COVID-19 recovered patients.
    Kumar A
    J Med Virol; 2022 Apr; 94(4):1272-1273. PubMed ID: 34905224
    [No Abstract]   [Full Text] [Related]  

  • 25. SARS-CoV-2 infection does not seem to worsen the clinical course of patients with oral autoimmune disease.
    Arduino PG; Gambino A; Broccoletti R
    Oral Dis; 2022 Nov; 28 Suppl 2():2593-2594. PubMed ID: 34343387
    [No Abstract]   [Full Text] [Related]  

  • 26. Interstitial pneumonia associated with autoimmune diseases: a possible mimicker of SARS-CoV-2 pneumonia.
    Pozzi MR; Faverio P; Varisco V; D'Andrea G; Giuffrida AC; Luppi F
    Intern Emerg Med; 2022 Mar; 17(2):577-581. PubMed ID: 34637076
    [No Abstract]   [Full Text] [Related]  

  • 27. COVID-associated mucormycosis (CAM): is the Delta variant a cause?
    Arakeri G; Rao Us V; Amaral Mendes R; Oeppen RS; Brennan PA
    Br J Oral Maxillofac Surg; 2022 May; 60(4):e529-e530. PubMed ID: 35115202
    [No Abstract]   [Full Text] [Related]  

  • 28. Imaging of COVID-19-associated craniofacial mucormycosis: a black and white review of the "black fungus".
    Sanghvi D; Kale H
    Clin Radiol; 2021 Nov; 76(11):812-819. PubMed ID: 34364672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Covid-19 and mucormycosis (Black Fungus): An epidemic within the pandemic.
    Gambhir RS; Aggarwal A; Bhardwaj A; Kaur A; Sohi RK; Mehta S
    Rocz Panstw Zakl Hig; 2021; 72(3):239-244. PubMed ID: 34553877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optical Coherence Tomography of Retinal Artery Occlusion Associated With Mucormycosis and COVID-19.
    Kaur R; Khan B; Sharma A
    JAMA Ophthalmol; 2021 Nov; 139(11):e214064. PubMed ID: 34787678
    [No Abstract]   [Full Text] [Related]  

  • 31. Can low-dose radiation therapy reduce the risk of mucormycosis in COVID-19 patients?
    Sharma DN; Welsh J; Kumar R
    J Cancer Res Ther; 2021; 17(6):1294-1296. PubMed ID: 34916356
    [No Abstract]   [Full Text] [Related]  

  • 32. Good response of low-dose steroid in a patient with COVID-19 pneumonia and autoimmune disease.
    Chang YY; Wang WH; Ku SW
    J Microbiol Immunol Infect; 2021 Oct; 54(5):1001-1002. PubMed ID: 34090821
    [No Abstract]   [Full Text] [Related]  

  • 33. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19.
    Elhamamsy S; Bayer T; Al-Kaffas M; Hatahet S; Grover M; Samdhani S; Nanda A; Gravenstein S
    R I Med J (2013); 2021 Oct; 104(8):19-21. PubMed ID: 34582509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Black Fungus Complicated with COVID-19 in a Man with Underlying Non-Hodgkin's Lymphoma.
    Nelwan EJ; Tunjungputri RN; Wardani RS; Wahyuningsih R
    Acta Med Indones; 2021 Jul; 53(3):349-351. PubMed ID: 34611076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
    Singh AK; Singh R; Joshi SR; Misra A
    Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative apnea trial and considerations regarding timing of tracheostomy in anesthetic planning for patient with COVID-19 disease.
    McGrath BA; Pelosi P; Schultz MJ; Brenner MJ
    J Clin Anesth; 2020 Dec; 67():110013. PubMed ID: 32890938
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of Iron Chelators in Mucormycosis.
    Mahalmani V; Sarma P; Prakash A; Medhi B
    Indian J Pharmacol; 2021; 53(4):261-263. PubMed ID: 34414902
    [No Abstract]   [Full Text] [Related]  

  • 38. COVID-19 patients for tracheostomy: Anesthetic and team considerations.
    Parekh RM; Lai YH
    J Clin Anesth; 2020 Oct; 65():109883. PubMed ID: 32447168
    [No Abstract]   [Full Text] [Related]  

  • 39. Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature.
    Pruthi H; Muthu V; Bhujade H; Sharma A; Baloji A; Ratnakara RG; Bal A; Singh H; Sandhu MS; Negi S; Chakrabarti A; Singhal M
    Mycopathologia; 2022 Feb; 187(1):31-37. PubMed ID: 34936060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy.
    Bhardwaj A; Roy V
    Indian J Pharmacol; 2021; 53(5):415-416. PubMed ID: 34854413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.